In the above article [Jutooru I, Chadalapaka G, Abdelrahim M, Basha MR, Samudio I, Konopleva M, Andreeff M, and Safe S (2010) Mol Pharmacol 78: 226–236], a statement regarding potential conflict of interest was omitted. The statement appears below.

M. Andreef and M. Konopleva have an ownership interest in and are consultants to Reata Pharmaceuticals, Inc.

The authors regret this error and apologize for any confusion or inconvenience it may have caused.

• Copyright © 2011 The American Society for Pharmacology and Experimental Therapeutics